Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
Brin
M F
MF
Department of Neurology, Mount Sinai Medical Center, New York, New York 10029, USA.
Blitzer
A
A
Stewart
C
C
D000328:Adult; D017668:Age of Onset; D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage*; D000974:Antibodies, Antinuclear / Q000097:blood; D001905:Botulinum Toxins / Q000008:administration & dosage*; D003413:Cricoid Cartilage; D004421:Dystonia / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013035:Spasm / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D014826:Vocal Cord Paralysis / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D014832:Voice Disorders / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology
D018726:Anti-Dyskinesia Agents; D000974:Antibodies, Antinuclear; D001905:Botulinum Toxins